Global Atherectomy and Thrombectomy Devices Market 2012-2016
SKU ID :TNV-10282564 | Published Date: 19-Apr-2013 | No. of pages: 55Description
TOC
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Research Methodology
5. Scope of the Report
Market Overview
Product Offerings
6. Market Landscape
6.1. Global Peripheral Vascular Devices Market
Market Size and Forecast
6.2. Key Market Segmentation
6.3. Global Atherectomy Devices Market
Market Size
Market Forecast
6.4. Key Market Segmentation of Atherectomy Devices
6.5. Atherectomy Devices Market in the US
Market Size and Forecast
6.6. Global Thrombectomy Devices Market
Market Size
Market Forecast
6.7. Key Market Segmentation of Thrombectomy Devices
6.8. Thrombectomy Devices Market in the US
Market Size and Forecast
6.9. Five Force Analysis
7. Geographical Segmentation
8. Key Leading Countries
USA
Japan
Germany
9. Rate of Incidence and Prevalence
Diabetes
Cancer
AIDS
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
17.1. Bayer AG
17.1.1. Business Overview
17.1.2. Business Segmentation
17.1.3. Key Information
17.1.4. SWOT Analysis
17.2. Boston Scientific Corp.
17.2.1. Business Overview
17.2.2. Business Segmentation
17.2.3. Key Information
17.2.4. SWOT Analysis
17.3. Covidien plc
17.3.1. Business Overview
17.3.2. Business Segmentation
17.3.3. Key Information
17.3.4. SWOT Analysis
17.4. Getinge AB
17.4.1. Business Overview
17.4.2. Business Segmentation
17.4.3. Key Information
17.4.4. SWOT Analysis
17.5. Vascular Solutions Inc.
17.5.1. Business Overview
17.5.2. Business Segmentation
17.5.3. Key Information
17.5.4. SWOT Analysis
18. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Peripheral Vascular Devices Market 2012–2016 (US$ billion)
Exhibit 2: Global Peripheral Vascular Devices Market by Category Segmentation
Exhibit 3: Global Atherectomy Devices Market 2012–2016 (US$ million)
Exhibit 4: Category Segmentation of Atherectomy Devices
Exhibit 5: Atherectomy Devices Market in the US 2012–2016 (US$ million)
Exhibit 6: Global Thrombectomy Devices Market 2012–2016 (US$ million)
Exhibit 7: Category Segmentation of Thrombectomy Devices
Exhibit 8: Thrombectomy Devices Market in the US 2012–2016 (US$ million)
Exhibit 9: Global Atherectomy Devices Market by Geographical Segmentation 2012
Exhibit 10: Global Thrombectomy Devices Market by Geographical Segmentation 2012
Exhibit 11: Global Atherectomy Devices Market by Vendor Segmentation 2012
Exhibit 12: Global Thrombectomy Devices Market by Vendor Segmentation 2012
Exhibit 13: Business Segmentation of Bayer AG
Exhibit 13: Business Segmentation of Boston Scientific Corp.
Exhibit 13: Business Segmentation of Covidien plc
Exhibit 13: Business Segmentation of Getinge AB
Exhibit 13: Business Segmentation of Vascular Solutions Inc.
Tables & Figures
Companies
Bayer AG, Boston Scientific Corp., Covidien plc, Getinge AB, Spectranetics Corp., Straub Medical AG, Vascular Solutions Inc.
,3M Co., American Heart Association Inc., Aerotel Medical Systems Ltd., Asian Heart Institute, Cook Medical Inc., ev3 Inc., Heartware International Ltd., Nihon Kohden Corp., Smith & Nephew plc, Sorin Group USA Inc., St. Jude Medical Inc., Terumo Medical Corp., Ventracor Ltd., Uscom Ltd.,Zoll Medical Corp.
- PRICE
-
$2500$4000